Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|23|4103-4110

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.23, 2013-12, pp. : 4103-4110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The mu opioid receptor: A new target for cancer therapy?

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2681-2688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer

By  

Oncology, Vol. 76, Iss. 1, 2008-11 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

The Role of an Androgen Receptor Polymorphism in the Clinical Outcome of Patients with Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Use of TTS Fentanyl as a Single Opioid for Cancer Pain Relief: A Safety and Efficacy Clinical Trial in Patients Naive to Mild or Strong Opioids

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 9-16

Karger

Access to resources Recommend Favorite

Low doses of transdermal fentanyl in opioid-naive patients with cancer pain

By Mercadante Sebastiano   Porzio Gianpiero   Ferrera Patrizia   Aielli Federica   Adile Claudio   Ficorella Corrado  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2765-2768

Informa Healthcare

Access to resources Recommend Favorite